• Listeria protein provides a CRISPR 'kill

    From ScienceDaily@1337:3/111 to All on Mon Jul 13 21:30:36 2020
    Listeria protein provides a CRISPR 'kill switch'

    Date:
    July 13, 2020
    Source:
    Cornell University
    Summary:
    A single protein derived from a common strain of bacteria found
    in the soil will offer scientists a more precise way to edit RNA.



    FULL STORY ==========================================================================
    A single protein derived from a common strain of bacteria found in the
    soil will offer scientists a more precise way to edit RNA.


    ==========================================================================
    The protein, called AcrVIA1, can halt the CRISPR-Cas13 editing process, according to new research from Cornell, Rockefeller University and the
    Memorial Sloan Kettering Cancer Center published in the journal Science
    July 3.

    "We're expanding our scientific toolbox to effectively use a CRISPR
    without causing side effects," said co-author Martin Wiedmann, Ph.D. '97,
    the Gellert Family Professor in Food Safety and director of Cornell's
    Food Safety Laboratory and Milk Quality Improvement Program. "Thanks to
    this bacterium, we're getting a chance to turn off and on our ability to
    make changes to RNA." CRISPR, or the clustered regularly interspaced
    short palindromic repeats, is a laboratory mechanism that can act like microscopic scissors and precisely edit the genes contained in DNA. Among
    the half-dozen types of CRISPRs in use today, CRISPR-Cas13 can edit RNA,
    which until now had lacked a brake in the editing process.

    Since SARS-CoV-2, the coronavirus that causes the COVID-19 disease, is
    an RNA virus, this new editing accessory may be useful to coronavirus researchers, the scientists said.

    Lead author Alex Meeske, postdoctoral researcher in the lab of senior
    author Luciano Marraffini, professor at Rockefeller University, had
    suspected that a protein (bacteriophage) housed in Listeria could be
    useful for RNA editing.

    At the start of this study, Meeske reached out to Wiedmann, a food
    safety expert, to obtain genetic bacterial samples from his food pathogen collection.

    Doctoral candidate in the Wiedmann laboratory Jingqiu Liao narrowed down
    the prospects from about 1,500 bacterial candidates to 62 strains.

    The Wiedmann lab transferred those samples to Rockefeller, where intern
    Alice Cassel sequenced the 62 strains and isolated 20 candidate proteins.

    One strain stood out: Listeria seeligeri, a harmless bacteria found
    everywhere in the soil. Unlike its fierce cousin -- the foodborne
    pathogen L.

    monocytogenes -- it does not cause human disease.

    The Rockefeller scientists found that the protein AcrVIA1 -- derived
    from L.

    seeligeri -- instantly stopped the CRISPR editing process. "AcrVIA1 can be
    very useful in controlling application of Cas13. Anything that the Cas13
    edits, this anti-CRISPR protein can shut off," Meeske said. "It's a 'kill switch' you can use during the CRISPR editing process, and it has become
    an additional tool we have at our disposal." Wiedmann explained that scientists can now work on RNA problems with more exacting means. "This
    tool gives us more precision," he said.

    The paper, "A Phage-Encoded Anti-CRISPR Enables Complete Evasion of Type
    VI- A CRISPR- 2 Cas Immunity," was co-written by senior author Dinshaw
    J. Patel and Ning Jia, both of Memorial Sloan Kettering, and Albina
    Kozlova of Rockefeller.


    ========================================================================== Story Source: Materials provided by Cornell_University. Original written
    by Blaine Friedlander. Note: Content may be edited for style and length.


    ========================================================================== Journal Reference:
    1. Alexander J. Meeske, Ning Jia, Alice K. Cassel, Albina Kozlova,
    Jingqiu
    Liao, Martin Wiedmann, Dinshaw J. Patel, Luciano A. Marraffini. A
    phage- encoded anti-CRISPR enables complete evasion of type
    VI-A CRISPR-Cas immunity. Science, 2020; 369 (6499): 54 DOI:
    10.1126/science.abb6151 ==========================================================================

    Link to news story: https://www.sciencedaily.com/releases/2020/07/200713144417.htm

    --- up 24 weeks, 6 days, 2 hours, 34 minutes
    * Origin: -=> Castle Rock BBS <=- Now Husky HPT Powered! (1337:3/111)